FOXO1 and metabolic disease: FOXO1, which was down-regulated in the group of animals with high CLA-c9t11 content, is highly expressed in tissues such as pancreas, liver, skeletal muscle and adipose tissue in response to insulin and is associated with metabolic disorders as dyslipidemia (Fig. 5).